Dana E. Angelini

MedicineHealth Professions

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial”.

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

The Lancet Haematology(2023)10.1016/s2352-3026(23)00119-9

N/A

1.4DataRank · unranked

38 citations

Scott D. Rothenberger, Robert Feldman, Danielle Nance, Andrew D. Leavitt, Lynn Malec +23 more

Patient-centered management of heavy menstrual bleeding while on anticoagulation: A survey study

European Journal of Obstetrics & Gynecology and Reproductive Biology(2025)10.1016/j.ejogrb.2025.114650

N/A

0DataRank · unranked

2 citations

Rushad Patell, Dana E. Angelini, Leben Tefera, Jordan K. Schaefer, Ang Li +7 more

An international survey of clinician recommendations for physical activity after venous thromboembolism

Thrombosis Research(2025)10.1016/j.thromres.2025.109478

N/A

0DataRank · unranked

0 citations

Pavlina Chrysafi, Dana E. Angelini, Jordan K. Schaefer, Ang Li, Shruti Chaturvedi +8 more